Vicore Pharma: Restoring lung function for IPF patients

Update: 2023-12-12

Description

Hear Vicore Pharma’s CEO, Ahmed Mousa speak to Optimum's Richard Staines on their new treatment for Idiopathic Pulmonary Fibrosis (IPF), C21. It aims to improve available treatments for patients of IPF by halting the progression of fibrosis and has the aim of restoring lung function.

Hosted on Acast. See acast.com/privacy for more information.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

SpliceBio: Celebrating progress in ophthalmology research on World Sight Day

2024-10-1011:42

Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine

2024-09-1214:24

Resolution Therapeutics: pioneering macrophage therapies for liver diseases

2024-08-0827:55

Q&A with Dr Ruth McKernan CBE: Neuroscientist, businesswoman and innovation leader

2024-07-2521:42

How AI is revolutionising drug research

2024-05-3023:39

Curve Therapeutics – Addressing challenging drug targets

2024-05-2312:39

Biotech IPOs make a comeback in 2024

2024-05-1620:55

Anglonordic Life Science Conference strikes optimistic note for ‘24

2024-05-0709:12

The challenges of recruitment for clinical trials

2024-04-0424:16

Lytix Biopharma – Innovations in Killing Cancer

2024-03-0717:07

Tackling Rare Diseases in 2024

2024-02-2938:09

International Day of Women & Girls in Science: Breaking barriers and channeling your inner cavewoman

2024-02-0827:40

Optimum's European Life Sciences Investor Survey 2024

2024-01-2317:46

Vicore Pharma: Restoring lung function for IPF patients

2023-12-1211:29

Optimum's Christmas charity special featuring Ariana Smiles

2023-12-0616:28

4SC: Creating a new treatment paradigm for CTCL

2023-11-2117:30

Episode 10: Optimum's 15th Annual Healthcare Investor Conference Special

2023-11-0208:45

Ask Eva: biopharma's market trends in 2023

2023-09-0714:09

Alchemab: The UK biotech that is revolutionising drug discovery

2023-08-2217:53

Poolbeg Pharma: Using AI to prepare for the next pandemic

2023-08-0816:27

00:00

1.0x

Vicore Pharma: Restoring lung function for IPF patients

#box-pro-ellipsis-172923650316059{-webkit-line-clamp:2;}Vicore Pharma: Restoring lung function for IPF patients

Vicore Pharma: Restoring lung function for IPF patients

Vicore Pharma: Restoring lung function for IPF patients